Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 164,894 | 214,877 | 100,461 | 151,461 | 87,426 |
| Marketable Securities | 285,605 | 255,102 | 283,328 | 258,317 | 211,941 |
| Receivables | 138,912 | 120,822 | 148,576 | 216,509 | 183,857 |
| Other current assets | 22,549 | 32,035 | 34,321 | 32,853 | 40,392 |
| TOTAL | $611,960 | $622,836 | $566,686 | $659,140 | $523,616 |
| Non-Current Assets | |||||
| PPE Net | 62,287 | 60,166 | 51,086 | 46,987 | 40,199 |
| Investments And Advances | 485,047 | 407,284 | 393,250 | 287,626 | 132,502 |
| Intangibles | 86,811 | 85,433 | 29,936 | 0 | 0 |
| Other Non-Current Assets | 32,615 | 28,949 | 8,897 | 5,330 | 4,144 |
| TOTAL | $666,760 | $581,832 | $483,169 | $339,943 | $176,845 |
| Total Assets | $1,278,720 | $1,204,668 | $1,049,855 | $999,083 | $700,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,137 | 15,107 | 15,077 | 15,048 | 15,019 |
| Accounts payable and accrued liabilities | 20,494 | 24,868 | 14,743 | 17,440 | 26,488 |
| Accrued Expenses | 17,689 | N/A | N/A | N/A | 8,446 |
| Other current liabilities | 45,056 | 89,308 | 65,305 | 43,520 | 26,843 |
| TOTAL | $105,310 | $147,158 | $121,524 | $196,530 | $130,115 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,947 | 5,899 | N/A | N/A |
| Other Non-Current Liabilities | 8,192 | 7,408 | 1,872 | 987 | 959 |
| TOTAL | $7,530 | $13,057 | $7,606 | $987 | $959 |
| Total Liabilities | $112,840 | $160,215 | $129,130 | $197,517 | $131,074 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,253 | 29,831 | 29,521 | 29,005 | 28,874 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 657,597 | 553,258 | 430,736 | 350,924 | 150,881 |
| Other shareholders' equity | 6,372 | 7,461 | 7,731 | -216 | 438 |
| TOTAL | $1,165,880 | $1,044,453 | $920,725 | $801,566 | $569,387 |
| Total Liabilities And Equity | $1,278,720 | $1,204,668 | $1,049,855 | $999,083 | $700,461 |